Concepedia

Whole-body positron emission tomography (PET) for diagnosis of residual mass in patients with lymphoma

Maike de Wit, D. Bumann, W. Beyer, Kenneth D. Herbst, M. Clausen, Dieter K. Hossfeld

Annals of Oncology · 1997 · 167 citations · 23 references

DOIFull text

Open access

Concepts

References

23

The applications of PET in clinical oncology.

Ludwig G. Strauss, Peter S. Conti · PubMed · 1991 · 855 citations

, , +17

Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction.

Kenneth Zasadny, Richard L. Wahl · Radiology · 1993 · 638 citations

, , +15

Metabolic trapping as a principle of oradiopharmaceutical design: some factors resposible for the biodistribution of [18F] 2-deoxy-2-fluoro-D-glucose.

Brian M. Gallagher, Joanna S. Fowler, Neal Gutterson et al. · PubMed · 1978 · 560 citations

, , +11

Imaging of lymphoma with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose: correlation with CT.

Joel S. Newman, Isaac R. Francis, Mark Kaminski et al. · Radiology · 1994 · 267 citations

, , +17

The significance of residual mediastinal abnormality on the chest radiograph following treatment for Hodgkin's disease.

John Radford, Richard Cowan, Malachi J. Flanagan et al. · Journal of Clinical Oncology · 1988 · 177 citations

, , +7